Updates matching "Maryland"

A recent poll by the American Cancer Society Cancer Action Network (ACS CAN) shows 8 in 10 (85%) Maryland voters view a candidate’s position on access to affordable, comprehensive health coverage as a vote-determining factor.

SILVER SPRING, MD – The American Cancer Society Cancer Action Network (ACS CAN) called on U.S. Senate candidates in Maryland to clearly state their commitments to fighting cancer, and one of the candidates, former Governor Larry Hogan, sat down with cancer survivors earlier today to discuss policies that alleviate

Today, the American Cancer Society Cancer Action Network, American Heart Association, American Lung Association and the Campaign for Tobacco-Free Kids issued the following statement:

The American Cancer Society Cancer Action Network (ACS CAN) called on U.S. Senate candidates in Maryland to clearly state their commitments to fighting cancer, and one of the candidates, Congressman David Trone, sat down with cancer survivors earlier today to discuss policies that alleviate the burden of cancer, a disease that continues to kill more than 1,600 Americans every day. The effort is part of ACS CAN’s national Cancer Votes program – the country’s leading voter education program for cancer-related issues and policies.

ANNAPOLIS, MD – February 27, 2024 – Tomorrow, the Maryland Senate Finance Committee will consider Senate Bill 595, which seeks to create more predictability for patients facing high out-of-pocket expenses for lifesaving medication. The following day, February 29, the House Health and Government Operations Committee will hold a hearing

ANNAPOLIS, MD – FEBRUARY 12, 2024 – Earlier tonight, American Cancer Society Cancer Action Network (ACS CAN) volunteers rallied at the Maryland State House as a part of their annual Cancer Action Day, urging lawmakers to support two proposals—the first, is a call to lawmakers to support an investment

ANNAPOLIS, MD – DECEMBER 20, 2023 – On January 1, 2024, Marylanders will gain access to biomarker testing when Chapter 322 of the Laws of 2023 takes effect for private insurers. The legislation, which requires coverage of biomarker testing when supported by scientific and medical evidence, received near-unanimous support

ANNAPOLIS, MD – MAY 3, 2023 – Today, Gov. Wes Moore will be signing HB 1217 / SB 805—among many other bills—into law. This legislation will increase insurance coverage for biomarker testing, making this form of precision medicine available to more Marylanders. The signing ceremony will take place today at

ANNAPOLIS, MD – APRIL 17, 2023 – Last week, HB 1217 / SB 805 landed on Governor Wes Moore’s desk following its near-unanimous passage in the Senate and House of Delegates and representing a victory for cancer patients across Maryland. The legislation aims to ensure biomarker testing is covered